Music during catheter ablation for atrial fibrillation under light sedation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults scheduled for a first-time radiofrequency catheter ablation for atrial fibrillation will be assigned to receive music through headphones during the procedure or to a control condition without music while managed with conscious (light) sedation. Study staff will track patient-reported anxiety and pain, medication (sedative/analgesic) needs, procedure metrics, and any safety events. The intervention is noninvasive and simple to deliver, using standardized music protocols during the ablation. Outcomes will compare comfort, hemodynamic stability, and resource use between the groups to determine whether music can meaningfully alter patient experience or medication requirements.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients undergoing first-time catheter radiofrequency ablation for atrial fibrillation at our center according to guideline recommendations;
2. Aged 18-80 years;
3. Willing to participate in the study and providing signed informed consent.

Exclusion Criteria:

1. Active psychiatric conditions necessitating pharmacotherapy;
2. Auditory/cognitive barriers to protocol compliance;
3. General anesthesia candidates;
4. Hybrid AF procedures (e.g., concomitant LAA occlusion);
5. Previous cardiac interventions;
6. Complex anatomies per preprocedural imaging (e.g., persistent left superior vena cava, cor triatriatum);
7. Recent (≤30 days) sedative/analgesic exposure."

Where it's running

• Shaoxing People's Hospital
  Shaoxing, Zhejiang, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Catheter ablation plus LAAC vs anticoagulation in frail elderly A-fib patients

  This study tests whether adding left atrial appendage closure to ablation is as good as using long-term blood thinners in frail people aged 75 and up with atrial fibrillation.

  Recruiting Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT07441382

• Substrate remodelling and targeted ablation for persistent atrial fibrillation

  This project will try using detailed 3D electrical mapping of the left atrium to guide targeted ablation (pulmonary vein reisolation, ganglionic plexi, and substrate ablation) for people with persistent atrial fibrillation undergoing their first catheter ablation.

  Recruiting Barts & The London NHS Trust · London · NCT07047235

• Catheter ablation for people with persistent atrial fibrillation and severe atrial functional mitral regurgitation

  This will test whether adding catheter ablation to usual medicines helps adults with persistent atrial fibrillation and moderate-to-severe or severe atrial functional mitral regurgitation reduce valve leakage and improve symptoms and outcomes.

  Recruiting at 12 sites Beijing Anzhen Hospital · Hefei, Anhui and 16 other locations · NCT06883864

• Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation

  This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.

  Recruiting St. Josefs-Hospital Wiesbaden GmbH · Wiesbaden · NCT07910370

• Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation

  This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.

  Recruiting East Sussex Healthcare NHS Trust · Eastbourne · NCT07900685

• Dexmedetomidine as add-on for refractory cancer pain in palliative care

  This study tests whether adding dexmedetomidine helps improve pain control for adults with cancer in palliative care whose pain remains high despite opioids.

  Recruiting St. Olavs Hospital · Drammen and 3 other locations · NCT07885475

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.